Trials / Unknown
UnknownNCT00418249
Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
Phase 2 Study of Topical AS101 for the Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- Rabin Medical Center · Academic / Other
- Sex
- Female
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to assess the safety and efficacy of topical AS101 as treatment for Female Androgenetic Alopecia (FAGA) in menopause women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AS101 |
Timeline
- First posted
- 2007-01-04
- Last updated
- 2007-01-04
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00418249. Inclusion in this directory is not an endorsement.